These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 17967639
1. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Daldal A, Odabasi O, Serbetcioglu B. Otolaryngol Head Neck Surg; 2007 Nov; 137(5):747-52. PubMed ID: 17967639 [Abstract] [Full Text] [Related]
3. Can intratympanic dexamethasone protect against cisplatin ototoxicity in mice with age-related hearing loss? Parham K. Otolaryngol Head Neck Surg; 2011 Oct; 145(4):635-40. PubMed ID: 21572077 [Abstract] [Full Text] [Related]
4. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D. Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950 [Abstract] [Full Text] [Related]
5. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model. Murphy D, Daniel SJ. Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888 [Abstract] [Full Text] [Related]
9. Dexamethasone-loaded chitosan-based genipin-cross-linked hydrogel for prevention of cisplatin induced ototoxicity in Guinea pig model. Yüksel Aslıer NG, Tağaç AA, Durankaya SM, Çalışır M, Ersoy N, Kırkım G, Yurdakoç K, Bağrıyanık HA, Yılmaz O, Sütay S, Güneri EA. Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():60-69. PubMed ID: 30974336 [Abstract] [Full Text] [Related]
10. Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study. Simsek G, Taş BM, Muluk NB, Azman M, Kılıç R. Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3287-3293. PubMed ID: 31531774 [Abstract] [Full Text] [Related]
12. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity. Nader ME, Théorêt Y, Saliba I. Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041 [Abstract] [Full Text] [Related]
14. Investigation of the cochlear effects of intratympanic steroids administered following acoustic trauma. Ozdogan F, Ensari S, Cakir O, Ozcan KM, Koseoglu S, Ozdas T, Gurgen SG, Dere H. Laryngoscope; 2012 Apr; 122(4):877-82. PubMed ID: 22374513 [Abstract] [Full Text] [Related]
15. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission. Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I. Oncology; 2006 Apr; 70(3):177-84. PubMed ID: 16757924 [Abstract] [Full Text] [Related]
16. Comparison of the protective effects of intratympanic dexamethasone and methylprednisolone against cisplatin-induced ototoxicity. Özel HE, Özdoğan F, Gürgen SG, Esen E, Genç S, Selçuk A. J Laryngol Otol; 2016 Mar; 130(3):225-34. PubMed ID: 26830667 [Abstract] [Full Text] [Related]
18. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. Knight KR, Kraemer DF, Winter C, Neuwelt EA. J Clin Oncol; 2007 Apr 01; 25(10):1190-5. PubMed ID: 17401008 [Abstract] [Full Text] [Related]